Vir, GSK win emergency use OK for Covid-fighting antibody
May 26, 2021 at 19:48 PM EDT
Ten months after starting clinical trials, the San Francisco company and its Big Pharma partner have a limited emergency use approval.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|